IRIS International Inc: All Recent News

• All recent news
• Earnings news

IRIS International to Present at the 21st Annual Piper Jaffray... 11/19/2009

CHATSWORTH, Calif., Nov. 19, 2009 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that Chairman, President and Chief Executive Officer Cesar Garcia will present an overview of the Company at the 21st Annual Piper Jaffray Health Care Conference on Tuesday, December 1, 2009 at 2:30 p.m. Eastern time at the New York Palace Hotel in New York City. GlobeNewswire

IRIS International's Sample Processing Division Enters... 11/17/2009

CHATSWORTH, Calif., Nov. 17, 2009 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer and marketer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that its Sample Processing Division has initiated shipments of its new StatSpin(R) OvaTube(TM) System for use in veterinary hospitals, clinics and reference laboratories to process fecal samples for the detection of ova and parasites. GlobeNewswire

IRIS International Names Lawrence J. Blecka, Ph.D., as Vice... 11/11/2009

CHATSWORTH, Calif., Nov. 11, 2009 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that it has appointed Lawrence J. Blecka, Ph.D., a senior executive with 30 years experience in medical device, diagnostics and biotechnology companies ranging from Fortune 500 to start-ups, as Vice President, Research and Development. Dr. Blecka will be responsible for overseeing all research and development of the Iris Diagnostics division, in... GlobeNewswire

IRIS International Reports Third Quarter Operating Income Up... 10/27/2009

CHATSWORTH, Calif., Oct. 27, 2009 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), bolstered by record contributions from sales of consumables and service and improved cost efficiencies, today announced third quarter operating income increased 7% to $2.3 million and net profits increased 18% to $1.9 million, or $0.11 per diluted share, the highest in any third quarter period, despite a 5% decline in overall revenue to $22.2 million as a result of lower U.S. instrument sales, for the third quarter ended September 30, 2009. This compares with operating income of $2.2 million and net... GlobeNewswire

IRIS International Reports Initiation of Pivotal Retrospective... 10/26/2009

CHATSWORTH, Calif., Oct. 26, 2009 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS) announced today that it has received Institutional Review Board (IRB) approvals from Duke University Medical Center, Memorial Sloan Kettering Cancer Institute, Eastern Virginia Medical School and the University of Washington Medical Center to immediately begin a multi-center 300 patient retrospective randomized clinical study utilizing its NADiA(TM) ProsVue(TM) ultra sensitive prostate-specific antigen diagnostic assay. GlobeNewswire

More News

Market Report

News by Symbol

Today's Investing Articles

Breaking News

News by Topic

News by Industry

MSNBC News

MSN Money

Search MSN Money

Message Boards

Site Status